Hepatitis E vaccine

被引:31
作者
Aggarwal, Rakesh [2 ]
Jameel, Shahid [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India
关键词
hepatitis; hepatitis E; HEV; vaccine;
D O I
10.1007/s12072-008-9071-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis E is an emerging disease in resource-poor regions of the world. It is estimated that about 2 billion people live in areas endemic for this disease. The inability to reproducibly culture hepatitis E virus makes it impossible to develop traditional live or inactivated vaccines. However, significant progress has been made in developing and testing recombinant subunit vaccines based on the viral capsid protein. This review summarizes these efforts.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 65 条
[1]   AGE-SPECIFIC PREVALENCE OF ANTIBODIES TO HEPATITIS-A AND HEPATITIS-E VIRUSES IN PUNE, INDIA, 1982 AND 1992 [J].
ARANKALLE, VA ;
TSAREV, SA ;
CHADHA, MS ;
ALLING, DW ;
EMERSON, SU ;
BANERJEE, K ;
PURCELL, RH .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :447-450
[2]   COMPLETE NUCLEOTIDE-SEQUENCE OF A HEPATITIS-E VIRUS ISOLATED FROM THE XINJIANG EPIDEMIC (1986-1988) OF CHINA [J].
AYE, TT ;
UCHIDA, T ;
MA, XZ ;
IIDA, F ;
SHIKATA, T ;
ZHUANG, H ;
WIN, KM .
NUCLEIC ACIDS RESEARCH, 1992, 20 (13) :3512-3512
[3]   EPIDEMIC HEPATITIS-E IN PAKISTAN - PATTERNS OF SEROLOGIC RESPONSE AND EVIDENCE THAT ANTIBODY TO HEPATITIS-E VIRUS PROTECTS AGAINST DISEASE [J].
BRYAN, JP ;
TSAREV, SA ;
IQBAL, M ;
TICEHURST, J ;
EMERSON, S ;
AHMED, A ;
DUNCAN, J ;
RAFIQUI, AR ;
MALIK, IA ;
PURCELL, RH ;
LEGTERS, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :517-521
[4]   Role of long-persisting human hepatitis E virus antibodies in protection [J].
Chauhan, A ;
Dilawari, JB ;
Sharma, R ;
Mukesh, M ;
Saroa, SR .
VACCINE, 1998, 16 (07) :755-756
[5]   DETECTION OF LONG-LASTING ANTIBODY TO HEPATITIS-E VIRUS IN A UNITED-STATES TRAVELER TO PAKISTAN [J].
DAWSON, GJ ;
MUSHAHWAR, IK ;
CHAU, KH ;
GITNICK, GL .
LANCET, 1992, 340 (8816) :426-427
[6]   Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice [J].
Deshmukh, Tejaswini M. ;
Lole, Kavita S. ;
Tripathy, Anuradha S. ;
Arankalle, Vidya A. .
VACCINE, 2007, 25 (22) :4350-4360
[7]   Recombinant hepatitis E virus genomes infectious for primates: Importance of capping and discovery of a cis-reactive element [J].
Emerson, SU ;
Zhang, M ;
Meng, XJ ;
Nguyen, H ;
St Claire, M ;
Govindarajan, S ;
Huang, YK ;
Purcell, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15270-15275
[8]   Recombinant vaccines for hepatitis E [J].
Emerson, SU ;
Purcell, RH .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (10) :462-466
[9]   SEROLOGIC IDENTIFICATION OF HEPATITIS-E VIRUS-INFECTIONS IN EPIDEMIC AND ENDEMIC SETTINGS [J].
FAVOROV, MO ;
FIELDS, HA ;
PURDY, MA ;
YASHINA, TL ;
ALEKSANDROV, AG ;
ALTER, MJ ;
YARASHEVA, DM ;
BRADLEY, DW ;
MARGOLIS, HS .
JOURNAL OF MEDICAL VIROLOGY, 1992, 36 (04) :246-250
[10]   Prevalence of antibodies to hepatitis E in two rural Egyptian communities [J].
Fix, AD ;
Abdel-Hamid, M ;
Purcell, RH ;
Shehata, MH ;
Abdel-Aziz, F ;
Mikhail, N ;
El Sebai, H ;
Nafeh, M ;
Habib, M ;
Arthur, RR ;
Emerson, SU ;
Strickland, GT .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2000, 62 (04) :519-523